Safety and immunogenicity of an optimized self-replicating RNA platform for low dose or single dose vaccine applications: a randomized, open label Phase I study in healthy volunteers

Publication: Nature Communications
UBC Author(s): Anna Blakney (Michael Smith Labs / Faculty of Science)
Volume: 16
Publication Date: December 2025